Skip to main content
NCBI home page
The Journal of Cell Biology logoLink to The Journal of Cell Biology
. 1992 May 1;117(3):679–685. doi: 10.1083/jcb.117.3.679

Transforming growth factor-beta stimulates collagen VII expression by cutaneous cells in vitro

PMCID: PMC2289436  PMID: 1572896

Abstract

Collagen VII, the major component of cutaneous anchoring fibrils is expressed at a low level by normal human keratinocytes and fibroblasts in vitro. In cocultures of these two cell types, signals from fibroblasts enhance expression of collagen VII by keratinocytes and vice versa. In this study, the effects of a possible mediator of such a stimulation, transforming growth factor-beta (TGF-beta), were investigated. Its effect on the expression and deposition of the highly insoluble collagen VII was assessed in a semiquantitative manner by a newly developed enzyme-linked immunoassay which is based on immunoblotting. In keratinocyte monocultures, 0.5-20 ng/ml of TGF-beta 2 induced a dose-dependent stimulation of collagen VII expression as measured per microgram of DNA. The maximal enhancement was about sevenfold compared to controls. The effect of TGF-beta 2 was observed already after 12 h, with a steady increase at least up to 3 d. As previous studies have implicated, untreated cocultures of keratinocytes and fibroblasts exhibited a higher basic level of collagen VII expression, which could be further stimulated about twofold by TGF-beta 2. Fibroblasts alone synthesized very minor quantities of collagen VII and could be only weakly stimulated by TGF-beta 2. This growth factor seems a specific enhancer of collagen VII since the expression of laminin, collagen IV, as well as total protein was increased to a much lesser extent. Our data suggest that TGF-beta may be an important mediator of epithelial-mesenchymal interactions and may regulate the synthesis of the anchoring fibrils at the skin basement membrane zone.

Full Text

The Full Text of this article is available as a PDF (812.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyce S. T., Ham R. G. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol. 1983 Jul;81(1 Suppl):33s–40s. doi: 10.1111/1523-1747.ep12540422. [DOI] [PubMed] [Google Scholar]
  2. Briggaman R. A., Wheeler C. E., Jr Epidermolysis bullosa dystrophica-recessive: a possible role of anchoring fibrils in the pathogenesis. J Invest Dermatol. 1975 Aug;65(2):203–211. doi: 10.1111/1523-1747.ep12598208. [DOI] [PubMed] [Google Scholar]
  3. Briggaman R. A., Wheeler C. E., Jr The epidermal-dermal junction. J Invest Dermatol. 1975 Jul;65(1):71–84. doi: 10.1111/1523-1747.ep12598050. [DOI] [PubMed] [Google Scholar]
  4. Bruckner-Tuderman L., Guscetti F., Ehrensperger F. Animal model for dermolytic mechanobullous disease: sheep with recessive dystrophic epidermolysis bullosa lack collagen VII. J Invest Dermatol. 1991 Apr;96(4):452–458. doi: 10.1111/1523-1747.ep12470130. [DOI] [PubMed] [Google Scholar]
  5. Bruckner-Tuderman L., Mitsuhashi Y., Schnyder U. W., Bruckner P. Anchoring fibrils and type VII collagen are absent from skin in severe recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 1989 Jul;93(1):3–9. doi: 10.1111/1523-1747.ep12277331. [DOI] [PubMed] [Google Scholar]
  6. Bruckner-Tuderman L., Niemi K. M., Kero M., Schnyder U. W., Reunala T. Type VII collagen is expressed but anchoring fibrils are defective in dystrophic epidermolysis bullosa inversa. Br J Dermatol. 1990 Mar;122(3):383–390. doi: 10.1111/j.1365-2133.1990.tb08287.x. [DOI] [PubMed] [Google Scholar]
  7. Bruckner-Tuderman L., Pfaltz M., Schnyder U. W. Cylindroma overexpresses collagen VII, the major anchoring fibril protein. J Invest Dermatol. 1991 May;96(5):729–734. doi: 10.1111/1523-1747.ep12470965. [DOI] [PubMed] [Google Scholar]
  8. Bruckner-Tuderman L., Schnyder U. W., Winterhalter K. H., Bruckner P. Tissue form of type VII collagen from human skin and dermal fibroblasts in culture. Eur J Biochem. 1987 Jun 15;165(3):607–611. doi: 10.1111/j.1432-1033.1987.tb11483.x. [DOI] [PubMed] [Google Scholar]
  9. Bruns R. R. A symmetrical, extracellular fibril. J Cell Biol. 1969 Aug;42(2):418–430. doi: 10.1083/jcb.42.2.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Burgeson R. E., Lunstrum G. P., Rokosova B., Rimberg C. S., Rosenbaum L. M., Keene D. R. The structure and function of type VII collagen. Ann N Y Acad Sci. 1990;580:32–43. doi: 10.1111/j.1749-6632.1990.tb17915.x. [DOI] [PubMed] [Google Scholar]
  11. Bächinger H. P., Morris N. P., Lunstrum G. P., Keene D. R., Rosenbaum L. M., Compton L. A., Burgeson R. E. The relationship of the biophysical and biochemical characteristics of type VII collagen to the function of anchoring fibrils. J Biol Chem. 1990 Jun 15;265(17):10095–10101. [PubMed] [Google Scholar]
  12. Goldsmith L. A., McCoon P., Partridge A., Lane A. T. Intraepithelial anchoring fibril components. Arch Dermatol. 1991 Jan;127(1):53–56. [PubMed] [Google Scholar]
  13. Gruschwitz M., Müller P. U., Sepp N., Hofer E., Fontana A., Wick G. Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest Dermatol. 1990 Feb;94(2):197–203. doi: 10.1111/1523-1747.ep12874503. [DOI] [PubMed] [Google Scholar]
  14. Hashimoto I., Schnyder U. W., Anton-Lamprecht I., Gedde-Dahl T., Jr, Ward S. Ultrastructural studies in epidermolysis bullosa hereditaria. III. Recessive dystrophic types with dermolytic blistering (Hallopeau-Siemens types and inverse type). Arch Dermatol Res. 1976 Aug 27;256(2):137–150. doi: 10.1007/BF00567360. [DOI] [PubMed] [Google Scholar]
  15. Hashiro M., Matsumoto K., Hashimoto K., Yoshikawa K. Stimulation of fibronectin secretion in cultured human keratinocytes by transforming growth factor-beta not by other growth inhibitory substances. J Dermatol. 1991 May;18(5):252–257. doi: 10.1111/j.1346-8138.1991.tb03078.x. [DOI] [PubMed] [Google Scholar]
  16. Heagerty A. H., Kennedy A. R., Leigh I. M., Purkis P., Eady R. A. Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH 7:2 monoclonal antibody: use in diagnosis. Br J Dermatol. 1986 Aug;115(2):125–131. doi: 10.1111/j.1365-2133.1986.tb05707.x. [DOI] [PubMed] [Google Scholar]
  17. Ignotz R. A., Massagué J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem. 1986 Mar 25;261(9):4337–4345. [PubMed] [Google Scholar]
  18. Keene D. R., Sakai L. Y., Lunstrum G. P., Morris N. P., Burgeson R. E. Type VII collagen forms an extended network of anchoring fibrils. J Cell Biol. 1987 Mar;104(3):611–621. doi: 10.1083/jcb.104.3.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. König A., Bruckner-Tuderman L. Epithelial-mesenchymal interactions enhance expression of collagen VII in vitro. J Invest Dermatol. 1991 Jun;96(6):803–808. doi: 10.1111/1523-1747.ep12474424. [DOI] [PubMed] [Google Scholar]
  20. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  21. Labarca C., Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 1980 Mar 1;102(2):344–352. doi: 10.1016/0003-2697(80)90165-7. [DOI] [PubMed] [Google Scholar]
  22. Lawrence D. A., Pircher R., Krycève-Martinerie C., Jullien P. Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol. 1984 Oct;121(1):184–188. doi: 10.1002/jcp.1041210123. [DOI] [PubMed] [Google Scholar]
  23. Lunstrum G. P., Sakai L. Y., Keene D. R., Morris N. P., Burgeson R. E. Large complex globular domains of type VII procollagen contribute to the structure of anchoring fibrils. J Biol Chem. 1986 Jul 5;261(19):9042–9048. [PubMed] [Google Scholar]
  24. Massagué J. The transforming growth factor-beta family. Annu Rev Cell Biol. 1990;6:597–641. doi: 10.1146/annurev.cb.06.110190.003121. [DOI] [PubMed] [Google Scholar]
  25. Mustoe T. A., Pierce G. F., Morishima C., Deuel T. F. Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J Clin Invest. 1991 Feb;87(2):694–703. doi: 10.1172/JCI115048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nanney L. B. Epidermal and dermal effects of epidermal growth factor during wound repair. J Invest Dermatol. 1990 May;94(5):624–629. doi: 10.1111/1523-1747.ep12876204. [DOI] [PubMed] [Google Scholar]
  27. Nathan C., Sporn M. Cytokines in context. J Cell Biol. 1991 Jun;113(5):981–986. doi: 10.1083/jcb.113.5.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Odermatt B. F., Lang A. B., Rüttner J. R., Winterhalter K. H., Trüeb B. Monoclonal antibodies to human type IV collagen: useful reagents to demonstrate the heterotrimeric nature of the molecule. Proc Natl Acad Sci U S A. 1984 Dec;81(23):7343–7347. doi: 10.1073/pnas.81.23.7343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Palade G. E., Farquhar M. G. A special fibril of the dermis. J Cell Biol. 1965 Oct;27(1):215–224. doi: 10.1083/jcb.27.1.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Parente M. G., Chung L. C., Ryynänen J., Woodley D. T., Wynn K. C., Bauer E. A., Mattei M. G., Chu M. L., Uitto J. Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):6931–6935. doi: 10.1073/pnas.88.16.6931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Partridge M., Green M. R., Langdon J. D., Feldmann M. Production of TGF-alpha and TGF-beta by cultured keratinocytes, skin and oral squamous cell carcinomas--potential autocrine regulation of normal and malignant epithelial cell proliferation. Br J Cancer. 1989 Oct;60(4):542–548. doi: 10.1038/bjc.1989.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Paulsson M., Aumailley M., Deutzmann R., Timpl R., Beck K., Engel J. Laminin-nidogen complex. Extraction with chelating agents and structural characterization. Eur J Biochem. 1987 Jul 1;166(1):11–19. doi: 10.1111/j.1432-1033.1987.tb13476.x. [DOI] [PubMed] [Google Scholar]
  33. Raghow R., Postlethwaite A. E., Keski-Oja J., Moses H. L., Kang A. H. Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest. 1987 Apr;79(4):1285–1288. doi: 10.1172/JCI112950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Regauer S., Seiler G. R., Barrandon Y., Easley K. W., Compton C. C. Epithelial origin of cutaneous anchoring fibrils. J Cell Biol. 1990 Nov;111(5 Pt 1):2109–2115. doi: 10.1083/jcb.111.5.2109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Roberts A. B., Flanders K. C., Kondaiah P., Thompson N. L., Van Obberghen-Schilling E., Wakefield L., Rossi P., de Crombrugghe B., Heine U., Sporn M. B. Transforming growth factor beta: biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis. Recent Prog Horm Res. 1988;44:157–197. doi: 10.1016/b978-0-12-571144-9.50010-7. [DOI] [PubMed] [Google Scholar]
  36. Roberts A. B., Heine U. I., Flanders K. C., Sporn M. B. Transforming growth factor-beta. Major role in regulation of extracellular matrix. Ann N Y Acad Sci. 1990;580:225–232. doi: 10.1111/j.1749-6632.1990.tb17931.x. [DOI] [PubMed] [Google Scholar]
  37. Rossi P., Karsenty G., Roberts A. B., Roche N. S., Sporn M. B., de Crombrugghe B. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell. 1988 Feb 12;52(3):405–414. doi: 10.1016/s0092-8674(88)80033-3. [DOI] [PubMed] [Google Scholar]
  38. Sakai L. Y., Keene D. R., Morris N. P., Burgeson R. E. Type VII collagen is a major structural component of anchoring fibrils. J Cell Biol. 1986 Oct;103(4):1577–1586. doi: 10.1083/jcb.103.4.1577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Shipley G. D., Pittelkow M. R., Wille J. J., Jr, Scott R. E., Moses H. L. Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium. Cancer Res. 1986 Apr;46(4 Pt 2):2068–2071. [PubMed] [Google Scholar]
  40. Smith L. T., Sybert V. P. Intra-epidermal retention of type VII collagen in a patient with recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 1990 Feb;94(2):261–264. doi: 10.1111/1523-1747.ep12874614. [DOI] [PubMed] [Google Scholar]
  41. Stanley J. R., Rubinstein N., Klaus-Kovtun V. Epidermolysis bullosa acquisita antigen is synthesized by both human keratinocytes and human dermal fibroblasts. J Invest Dermatol. 1985 Dec;85(6):542–545. doi: 10.1111/1523-1747.ep12277377. [DOI] [PubMed] [Google Scholar]
  42. Tidman M. J., Eady R. A. Evaluation of anchoring fibrils and other components of the dermal-epidermal junction in dystrophic epidermolysis bullosa by a quantitative ultrastructural technique. J Invest Dermatol. 1985 May;84(5):374–377. doi: 10.1111/1523-1747.ep12265460. [DOI] [PubMed] [Google Scholar]
  43. Tidman M. J., Eady R. A. Ultrastructural morphometry of normal human dermal-epidermal junction. The influence of age, sex, and body region on laminar and nonlaminar components. J Invest Dermatol. 1984 Dec;83(6):448–453. doi: 10.1111/1523-1747.ep12273562. [DOI] [PubMed] [Google Scholar]
  44. Timpl R. Structure and biological activity of basement membrane proteins. Eur J Biochem. 1989 Apr 1;180(3):487–502. doi: 10.1111/j.1432-1033.1989.tb14673.x. [DOI] [PubMed] [Google Scholar]
  45. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Tucker R. F., Branum E. L., Shipley G. D., Ryan R. J., Moses H. L. Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets. Proc Natl Acad Sci U S A. 1984 Nov;81(21):6757–6761. doi: 10.1073/pnas.81.21.6757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Varga J., Rosenbloom J., Jimenez S. A. Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J. 1987 Nov 1;247(3):597–604. doi: 10.1042/bj2470597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Vollberg T. M., Sr, George M. D., Jetten A. M. Induction of extracellular matrix gene expression in normal human keratinocytes by transforming growth factor beta is altered by cellular differentiation. Exp Cell Res. 1991 Mar;193(1):93–100. doi: 10.1016/0014-4827(91)90542-3. [DOI] [PubMed] [Google Scholar]
  49. Wikner N. E., Persichitte K. A., Baskin J. B., Nielsen L. D., Clark R. A. Transforming growth factor-beta stimulates the expression of fibronectin by human keratinocytes. J Invest Dermatol. 1988 Sep;91(3):207–212. doi: 10.1111/1523-1747.ep12464997. [DOI] [PubMed] [Google Scholar]
  50. Woessner J. F., Jr Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991 May;5(8):2145–2154. [PubMed] [Google Scholar]
  51. Woodley D. T., Burgeson R. E., Lunstrum G., Bruckner-Tuderman L., Reese M. J., Briggaman R. A. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest. 1988 Mar;81(3):683–687. doi: 10.1172/JCI113373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Yurchenco P. D., Schittny J. C. Molecular architecture of basement membranes. FASEB J. 1990 Apr 1;4(6):1577–1590. doi: 10.1096/fasebj.4.6.2180767. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press

RESOURCES